Literature DB >> 9009996

Clinical and molecular analysis of a large family with three distinct phenotypes of progressive muscular dystrophy.

S N Illarioshkin1, I A Ivanova-Smolenskaya, H Tanaka, N V Vereshchagin, E D Markova, V V Poleshchuk, S M Lozhnikova, V S Sukhorukov, S A Limborska, P A Slominsky, K B Bulayeva, S Tsuji.   

Abstract

We describe a unique six-generation, highly consanguineous family originating from an isolated mountainous village in the Russian province of Daghestan. Three separate clinical phenotypes of progressive muscular dystrophy were identified in this large family. Seven patients developed a classical limb-girdle variant of muscular dystrophy (LGMD), with disease onset at 15-30 years and loss of ambulation within a 25-year course. The second group included three patients with a slowly progressive distal myopathy first manifested in the late teens and confined to the tibial and calf muscles. Each of these two phenotypes segregated independently as an autosomal recessive trait, and muscle biopsies showed non-specific myopathic changes. Lastly, two male siblings exhibited an atypical variant of Duchenne muscular dystrophy confirmed by detection of a deletion in the dystrophin gene. To clarify the molecular basis of the polymorphic autosomal recessive form of muscular dystrophy in this kindred, we performed molecular genetic studies on 67 family members and obtained significant evidence for linkage to chromosome 2p. A maximum pairwise lod (logarithm of odds) score of 5.64 was achieved at the zero recombination fraction (i.e. at theta = 0.00) for locus D2S291; multipoint linkage analysis confirmed the most likely location of a mutant gene near D2S291. The patients with LGMD and those with the distal muscular dystrophy phenotype share a common affected homozygous haplotype associated with the same founder chromosome; key recombinants defined D2S286 and D2S292 to be the closest loci flanking the mutant gene. Remarkably, two clinically distinct forms of autosomal recessive muscular dystrophy, LGMD type 2B (LGMD2B) and Miyoshi myopathy, were recently mapped to the same locus. We suggest that all three chromosome 2p-linked conditions may represent allelic disorders, i.e. different phenotypic expressions of a single gene.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9009996     DOI: 10.1093/brain/119.6.1895

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  7 in total

1.  The ascertainment of multiplex schizophrenia pedigrees from Daghestan genetic isolates (Northern Caucasus, Russia).

Authors:  K B Bulayeva; S M Leal; T A Pavlova; R Kurbanov; S Coover; O Bulayev; W Byerley
Journal:  Psychiatr Genet       Date:  2000-06       Impact factor: 2.458

2.  Assignment of the tibial muscular dystrophy locus to chromosome 2q31.

Authors:  H Haravuori; P Mäkelä-Bengs; B Udd; J Partanen; L Pulkkinen; H Somer; L Peltonen
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

3.  Clinical and pathological characteristics of four Korean patients with limb-girdle muscular dystrophy type 2B.

Authors:  Seung-Hun Oh; Seong-Woong Kang; Jin-Goo Lee; Sang-Jun Na; Tai-Seung Kim; Young-Chul Choi
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

4.  Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: clinical description and gene localization to 5q31.

Authors:  H Feit; A Silbergleit; L B Schneider; J A Gutierrez; R P Fitoussi; C Réyès; G A Rouleau; B Brais; C E Jackson; J S Beckmann; E Seboun
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

5.  A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis.

Authors:  Agnes L Nishimura; Miguel Mitne-Neto; Helga C A Silva; Antônio Richieri-Costa; Susan Middleton; Duilio Cascio; Fernando Kok; João R M Oliveira; Tom Gillingwater; Jeanette Webb; Paul Skehel; Mayana Zatz
Journal:  Am J Hum Genet       Date:  2004-09-15       Impact factor: 11.025

6.  Twenty-Year Clinical Progression of Dysferlinopathy in Patients from Dagestan.

Authors:  Zoya R Umakhanova; Sergei N Bardakov; Mikhail O Mavlikeev; Olga N Chernova; Raisat M Magomedova; Patimat G Akhmedova; Ivan A Yakovlev; Gimat D Dalgatov; Valerii P Fedotov; Artur A Isaev; Roman V Deev
Journal:  Front Neurol       Date:  2017-03-08       Impact factor: 4.003

7.  Dysferlinopathy in Switzerland: clinical phenotypes and potential founder effects.

Authors:  Jens A Petersen; Thierry Kuntzer; Dirk Fischer; Maja von der Hagen; Angela Huebner; Veronika Kana; Johannes A Lobrinus; Wolfram Kress; Elisabeth J Rushing; Michael Sinnreich; Hans H Jung
Journal:  BMC Neurol       Date:  2015-10-06       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.